Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist representation of a molecule symbolizing drug development in biopharma.

May 21, 2026

Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling

Recent partnerships among major biopharma companies highlight the growing role of artificial intelligence in drug development, with Eli Lilly, Bristol Myers Squibb (BMS), and Incyte making significant moves to enhance their operations through advanced machine learning technologies.BMS has entered into a collaboration with Anthropic to integrate its Claude AI model into various stages of drug development, including clinical and manufacturing processes. This initiative aims to unlock valuable data
A pill bottle on a lab shelf in a dimly lit setting

May 21, 2026

BMS-Claude Agreement Signals AI Integration Shift in Pharma

Bristol Myers Squibb (BMS) has formed a strategic partnership with Anthropic to implement the Claude Enterprise platform across its global operations, marking a significant advancement in the integration of generative AI within the pharmaceutical sector.This collaboration aims to establish Claude as a comprehensive "intelligence platform" that will enhance various functions, including research, clinical development, and commercial operations. The initiative is set to provide over 30,000 BMS empl
A vial of AmBisome on a laboratory shelf in a dimly lit setting.

May 21, 2026

Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi

Recent collaborations from Gilead Sciences and Johnson & Johnson highlight the pharmaceutical and medtech sectors' commitment to tackling significant healthcare issues through cross-industry partnerships.Gilead Sciences has renewed its five-year partnership with the World Health Organization (WHO) to combat visceral leishmaniasis (VL), a severe parasitic disease. As part of this collaboration, Gilead will supply over 400,000 vials of AmBisome and contribute $9.2 million by 2030, focusing on regi
A stethoscope on a patient's arm in a clinical setting

May 21, 2026

AI, remote care drive new models for Australian medtech

Artificial intelligence and remote monitoring are transforming the Australian medtech landscape, as highlighted during the recent Ausmedtech conference in Perth. Keynote speakers emphasized that AI and remote care technologies are not only enhancing device capabilities but are also revolutionizing healthcare delivery models. The integration of these technologies is fostering a shift towards more personalized and need-based innovations within the sector. This evolution is significant, as it align
A vial of enzyme sample on a lab bench with shelves of reagents in the background.

May 21, 2026

Imperagen’s £5M Bid Powers AI Enzyme Design Leap

Imperagen has secured £5 million in funding to enhance its AI-driven enzyme design platform, aiming to revolutionize the biocatalyst development landscape.The latest funding round brings Imperagen's total to £8.5 million since its inception in 2021, allowing the company to expand its research and development efforts in AI enzyme design. This financial boost will support hiring in key areas such as computational chemistry and automation, with plans to double its workforce within the next year. Th
A syringe and vaccine vial in a dimly lit lab setting

May 21, 2026

AI, Defense, and Life Sciences: What Top Executives Believe Will Shape the Economy

Executives from various sectors recently gathered to discuss the future economic landscape, revealing a significant shift in focus towards artificial intelligence, defense, and life sciences.At the Milken Institute Global Conference, leaders from diverse industries engaged in a candid dialogue aimed at identifying the key sectors and figures likely to shape the economy in the coming years. The discussions highlighted a notable pivot from the previous decade's focus on software and e-commerce to
A minimalist representation of an enzyme and chemical bond in dark colors with lime accents.

May 21, 2026

Manchester AI biotech spin-out lands £5m to “rewrite chemical reactions”

Manchester-based biotech spin-out Imperagen has successfully raised £5 million in seed funding to enhance its AI-driven enzyme engineering platform, a venture stemming from research conducted at The University of Manchester.This funding round, led by PXN Ventures with participation from existing investors IQ Capital and Northern Gritstone, brings Imperagen's total funding to £8.5 million. Established in 2021 by researchers Dr. Andrew Almond, Dr. Andrew Currin, and Dr. Tim Eyes, the company aims
A stethoscope on a bedside table beside a patient's arm in a dimly lit hospital room.

May 21, 2026

Digital Care Continuity, Not AI Hype, Is Europe's Priority

Recent insights from the Black Book HIMSS26 Europe Pulse survey reveal that hospital buyers in Europe prioritize digital care continuity over the hype surrounding artificial intelligence. This shift in focus highlights a growing recognition of the need for seamless digital health solutions in patient care.The survey indicates that healthcare leaders are increasingly directing their investments towards technologies that enhance continuity of care. This involves integrating various digital health
A checkmark over a clipboard representing compliance and validation in life sciences.

May 21, 2026

Zifo to Showcase AI-Driven Validation and Compliance Innovations at CSV & CSA University Europe 2026 in Dublin

Zifo is set to showcase its advancements in AI-driven validation and compliance at the upcoming CSV & CSA University Europe 2026, emphasizing the industry's need for AI-ready compliance ecosystems.Taking place on June 2-3, 2026, in Dublin, Ireland, this conference will focus on the intersection of artificial intelligence, compliance, and digital transformation in the life sciences sector. As a Gold Sponsor, Zifo will contribute to discussions on Computer Software Assurance (CSA) and Computer Sys
A minimalist representation of a chatbot in a speech bubble format against a dark background.

May 21, 2026

One in seven use AI chatbots instead of seeing a doctor, poll finds

A recent poll reveals that one in seven adults in the UK now prefer using AI chatbots for healthcare advice over consulting a doctor, highlighting a significant shift in health-seeking behavior.Conducted by researchers at King’s College London, the survey of 2,083 adults aged 18 and older indicates that convenience (46%) and NHS waiting lists (25%) are major factors driving this preference. Additionally, many users are motivated by curiosity (45%) and uncertainty about the seriousness of their h
A barcode scanner scanning a packaged pharmaceutical product in a warehouse setting.

May 21, 2026

AI-Driven Traceability Platforms Reshape Indian Pharma’s Push for Global Compliance and Supply Chain Visibility

AI technology is transforming the Indian pharmaceutical landscape, particularly in enhancing compliance and supply chain transparency.Annora Pharma, a subsidiary of Hetero Group, is collaborating with AltiusHub to upgrade its drug traceability system through AI-driven serialization and regulatory compliance technologies. This initiative aims to boost serialization efficiency by 45% and provide real-time visibility throughout its global supply chain, catering to major markets such as the US, EU,
A heart symbolizing AI in healthcare

May 21, 2026

AI-Powered Digital Health Systems Poised to Strengthen India’s Healthcare Delivery Ecosystem

The Uttar Pradesh AI & Health Innovation Conference 2026 highlighted the transformative potential of AI in enhancing India's healthcare delivery systems.Held on January 12-13, 2026, the conference brought together a diverse group of stakeholders, including policymakers and technology leaders, to explore how AI can be effectively integrated into digital health systems. Shri Sunil Kumar Barnwal, CEO of the National Health Authority, emphasized that AI has matured from a theoretical concept to a pr